Health
Oxford/AstraZeneca vaccine 80% effective against B1.617.2 variant: UK study – Times of India
India News: Two doses from either the Oxford/AstraZeneca or the Pfizer vaccine are over 80 per cent effective in preventing infection from the B1.617.2 variant…
Oxford/AstraZeneca vaccine 80% effective against B1.617.2 variant: UK study
- News
- India News
- Oxford/AstraZeneca vaccine 80% effective against B1.617.2 variant: UK study
Continue Reading
-
General22 hours agoOf saints and sinners | The Spectator Australia
-
General22 hours agoWhy the nation needs the Nationals to ditch Net Zero
-
General22 hours agoChina and Philippines trade blame over latest South China Sea clash
-
General22 hours agoSmall plane crashes into San Diego neighbourhood, setting homes and vehicles on fire